Injected sensor could offer new window into blood flow problems
NCT ID NCT04514861
Summary
This study is testing a new wireless device designed to monitor oxygen levels in the tissue of people with peripheral artery disease (PAD), a condition that reduces blood flow to the limbs. A small, injectable sensor is placed under the skin to continuously measure oxygen, and the readings are compared to a standard external monitor. The goal is to see if this new sensor can accurately track changes in tissue oxygen when blood flow is temporarily altered, potentially offering a new way to assess the severity of PAD.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
San Francisco General Hospital
San Francisco, California, 94110, United States
-
San Francisco Veterans Affairs Medical Center (SFVAMC)
San Francisco, California, 94121, United States
-
UCSF Medical Center
San Francisco, California, 94143, United States
Conditions
Explore the condition pages connected to this study.